John Rwegasha

973 total citations
14 papers, 239 citations indexed

About

John Rwegasha is a scholar working on Epidemiology, Hepatology and Infectious Diseases. According to data from OpenAlex, John Rwegasha has authored 14 papers receiving a total of 239 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Epidemiology, 11 papers in Hepatology and 3 papers in Infectious Diseases. Recurrent topics in John Rwegasha's work include Hepatitis C virus research (11 papers), Hepatitis B Virus Studies (10 papers) and Liver Disease Diagnosis and Treatment (5 papers). John Rwegasha is often cited by papers focused on Hepatitis C virus research (11 papers), Hepatitis B Virus Studies (10 papers) and Liver Disease Diagnosis and Treatment (5 papers). John Rwegasha collaborates with scholars based in Tanzania, United Kingdom and France. John Rwegasha's co-authors include Tumaini Nagu, Ewaldo Komba, Maud Lemoine, Zameer Mohamed, Jessie Mbwambo, Yusuke Shimakawa, Stéphane Chevaliez, Simon D. Taylor‐Robinson, Mark Thursz and Lila Poiteau and has published in prestigious journals such as Journal of Hepatology, BMC Infectious Diseases and Liver International.

In The Last Decade

John Rwegasha

14 papers receiving 232 citations

Peers

John Rwegasha

EPIDE

HEPAT

HEALT

MTI

Stephen Ko United States

Edina Amponsah‐Dacosta South Africa

Maria A. Corcorran United States

Nicole Allard Australia

Nicolas Rouveau France

Yaping Qiao China

Hasan Abbas Zaheer Pakistan

Simnikiwe H. Mayaphi South Africa

Analía Urueña Argentina

Sonjelle Shilton Switzerland

Stephen Ko United States

John Rwegasha

336 ×1.8

EPIDE

297 ×1.8

HEPAT

106 ×1.5

36 ×0.9

HEALT

9 ×0.6

MTI

Citations per year, relative to John Rwegasha John Rwegasha (= 1×) peers Stephen Ko

Countries citing papers authored by John Rwegasha

Since Specialization

Citations

This map shows the geographic impact of John Rwegasha's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Rwegasha with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Rwegasha more than expected).

Fields of papers citing papers by John Rwegasha

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John Rwegasha. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Rwegasha. The network helps show where John Rwegasha may publish in the future.

Co-authorship network of co-authors of John Rwegasha

This figure shows the co-authorship network connecting the top 25 collaborators of John Rwegasha. A scholar is included among the top collaborators of John Rwegasha based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John Rwegasha. John Rwegasha is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Mwakawanga, Dorkasi L., Ritah Mutagonda, Wigilya P. Mikomangwa, et al.. (2025). Improving the provision of clinical pharmacy services in low- and middle-income countries: a qualitative study in tertiary health facilities in Tanzania. BMJ Public Health. 3(1). e001776–e001776. 3 indexed citations

Kilonzi, Manase, Ritah Mutagonda, Dorkasi L. Mwakawanga, et al.. (2023). Barriers and facilitators of integration of pharmacists in the provision of clinical pharmacy services in Tanzania. BMC Primary Care. 24(1). 72–72. 11 indexed citations

Mohamed, Zameer, Nick Scott, Shevanthi Nayagam, et al.. (2021). Cost effectiveness of simplified HCV screening-and-treatment interventions for people who inject drugs in Dar-es-Salaam, Tanzania. International Journal of Drug Policy. 99. 103458–103458. 5 indexed citations

Lemoine, Maud, Jin Un Kim, Gibril Ndow, et al.. (2020). Effect of the COVID-19 pandemic on viral hepatitis services in sub-Saharan Africa. The Lancet. Gastroenterology & hepatology. 5(11). 966–967. 23 indexed citations

Rwegasha, John, Shaun Shadaker, Geoff Beckett, et al.. (2020). The establishment of hepatitis B care and treatment clinics with viral load testing capacity in the United Republic of Tanzania: a demonstration project following WHO guidelines, Dar es Salaam, 2017–2019. Journal of Hepatology. 73. S870–S870. 1 indexed citations

Scott, Nick, Zameer Mohamed, John Rwegasha, et al.. (2019). Upscaling prevention, testing and treatment to control hepatitis C as a public health threat in Dar es Salaam, Tanzania: A cost-effectiveness model. International Journal of Drug Policy. 88. 102634–102634. 9 indexed citations

Mohamed, Zameer, Jin Un Kim, Mabula Kasubi, et al.. (2019). High prevalence and poor linkage to care of transfusion‐transmitted infections among blood donors in Dar‐es‐Salaam, Tanzania. Journal of Viral Hepatitis. 26(6). 750–756. 20 indexed citations

Mohamed, Zameer, Jessie Mbwambo, John Rwegasha, et al.. (2019). In‐field evaluation of Xpert® HCV viral load Fingerstick assay in people who inject drugs in Tanzania. Liver International. 40(3). 514–521. 27 indexed citations

Poiteau, Lila, Alexandre Soulier, Maud Lemoine, et al.. (2018). Performance of a new rapid diagnostic test for the detection of antibodies to hepatitis C virus. Journal of Virological Methods. 261. 153–155. 10 indexed citations

10.

Mohamed, Zameer, John Rwegasha, Jin Un Kim, et al.. (2018). The hepatitis C cascade of care in people who inject drugs in Dar es Salaam, Tanzania. Journal of Viral Hepatitis. 25(12). 1438–1445. 20 indexed citations

11.

Lambdin, Barrot H., Jennifer Lorvick, Jessie Mbwambo, et al.. (2017). Prevalence and predictors of HCV among a cohort of opioid treatment patients in Dar es Salaam, Tanzania. International Journal of Drug Policy. 45. 64–69. 16 indexed citations

12.

Nagu, Tumaini, et al.. (2017). Hepatitis B vaccination coverage among healthcare workers at national hospital in Tanzania: how much, who and why?. BMC Infectious Diseases. 17(1). 786–786. 58 indexed citations

13.

Mohamed, Zameer, Jessie Mbwambo, Yusuke Shimakawa, et al.. (2017). Clinical utility of HCV core antigen detection and quantification using serum samples and dried blood spots in people who inject drugs in Dar‐es‐Salaam, Tanzania. Journal of the International AIDS Society. 20(1). 21856–21856. 35 indexed citations

14.

Mohamed, Zameer, Jessie Mbwambo, John Rwegasha, et al.. (2017). High prevalence of chronic hepatitis C in injecting drug users in Tanzania, East Africa: a neglected burden of disease. Journal of Hepatology. 66(1). S416–S416. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact